{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:02:55Z","timestamp":1756512175487,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.remnie.2025.500113","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:36:45Z","timestamp":1738755405000},"page":"500113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET\/CT parameters and inflammatory markers"],"prefix":"10.1016","volume":"44","author":[{"given":"Gokmen Umut","family":"Erdem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Vural Topuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esranur","family":"Acar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanju","family":"Kapagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma","family":"Yetim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykut","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simay","family":"Gurocak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Usul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytul Hande","family":"Yardimci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilufer","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.remnie.2025.500113_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/gastro\/gow017","article-title":"Neoadjuvant treatment of rectal cancer: where are we now?","volume":"4","author":"Kalyan","year":"2016","journal-title":"Gastroenterol Rep (Oxf)."},{"issue":"7","key":"10.1016\/j.remnie.2025.500113_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5306\/wjco.v9.i7.148","article-title":"Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: a retrospective review of our data","volume":"9","author":"Tong","year":"2018","journal-title":"World J Clin Oncol."},{"issue":"1","key":"10.1016\/j.remnie.2025.500113_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.remnie.2025.500113_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.remnie.2025.500113_bib0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.remnie.2025.500113_bib0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.remnie.2025.500113_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12957-021-02415-y","article-title":"A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy","volume":"19","author":"Yu","year":"2021","journal-title":"World J Surg Oncol."},{"issue":"1","key":"10.1016\/j.remnie.2025.500113_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12672-021-00405-w","article-title":"Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer","volume":"12","author":"Caruso","year":"2021","journal-title":"Discov Oncol."},{"issue":"1","key":"10.1016\/j.remnie.2025.500113_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijrobp.2008.07.050","article-title":"Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation","volume":"74","author":"Konski","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"10.1016\/j.remnie.2025.500113_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology."},{"issue":"2","key":"10.1016\/j.remnie.2025.500113_bib0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500113_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.critrevonc.2016.12.001","article-title":"ECCO essential requirements for quality cancer care: colorectal cancer. A critical review","volume":"110","author":"Beets","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"issue":"2","key":"10.1016\/j.remnie.2025.500113_bib0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2003.09.058","article-title":"18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation","volume":"58","author":"Calvo","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"10.1016\/j.remnie.2025.500113_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/annonc\/mdq433","article-title":"Prospective study on the FDG-PET\/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer","volume":"22","author":"Martoni","year":"2011","journal-title":"Ann Oncol."},{"key":"10.1016\/j.remnie.2025.500113_bib0075","article-title":"Clinical significance of the maximum standardized uptake value on positron emission tomography to predict treatment response and outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy","author":"Tsuneki","year":"2024","journal-title":"Surg Today."},{"issue":"5","key":"10.1016\/j.remnie.2025.500113_bib0080","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00280-013-2114-0","article-title":"Clinical implications of initial FDG-PET\/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"71","author":"Lee","year":"2013","journal-title":"Cancer Chemother Pharmacol."},{"issue":"1","key":"10.1016\/j.remnie.2025.500113_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MNM.0000000000001638","article-title":"18F-FDG PET\/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer","volume":"44","author":"Ebinc","year":"2023","journal-title":"Nucl Med Commun."},{"issue":"8","key":"10.1016\/j.remnie.2025.500113_bib0090","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00261-016-0698-7","article-title":"Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study","volume":"41","author":"Li","year":"2016","journal-title":"Abdom Radiol (NY)."},{"issue":"2","key":"10.1016\/j.remnie.2025.500113_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12029-021-00608-y","article-title":"The predictive value of baseline volumetric PET\/CT parameters on treatment response and prognosis in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"53","author":"Sakin","year":"2022","journal-title":"J Gastrointest Cancer."},{"issue":"5","key":"10.1016\/j.remnie.2025.500113_bib0100","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00261-014-0277-8","article-title":"Comparison of (18)F-FDG PET\/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer","volume":"40","author":"Altini","year":"2015","journal-title":"Abdom Imaging."},{"issue":"3","key":"10.1016\/j.remnie.2025.500113_bib0105","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.21873\/anticanres.11470","article-title":"Systemic inflammatory response after preoperative chemoradiotherapy can affect oncologic outcomes in locally advanced rectal cancer","volume":"37","author":"Lee","year":"2017","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.remnie.2025.500113_bib0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0300891618792476","article-title":"Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy","volume":"105","author":"Kim","year":"2019","journal-title":"Tumori."},{"issue":"28","key":"10.1016\/j.remnie.2025.500113_bib0115","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2217\/fon-2019-0389","article-title":"Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer","volume":"15","author":"Li","year":"2019","journal-title":"Future Oncol."},{"issue":"9","key":"10.1016\/j.remnie.2025.500113_bib0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00066-016-0988-6","article-title":"Neoadjuvant chemoradiotherapy of rectal carcinoma: baseline hematologic parameters influencing outcomes","volume":"192","author":"Hodek","year":"2016","journal-title":"Strahlenther Onkol."},{"key":"10.1016\/j.remnie.2025.500113_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13014-014-0295-2","article-title":"Baseline neutrophil-lymphocyte ratio (&\/=2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation","volume":"9","author":"Shen","year":"2014","journal-title":"Radiat Oncol."},{"issue":"4","key":"10.1016\/j.remnie.2025.500113_bib0130","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ijrobp.2007.04.047","article-title":"Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer","volume":"69","author":"Yoon","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"10.1016\/j.remnie.2025.500113_bib0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/DCR.0000000000002245","article-title":"Rectal cancer: clinical and molecular predictors of a complete response to total neoadjuvant therapy","volume":"66","author":"Chapman","year":"2023","journal-title":"Dis Colon Rectum."},{"issue":"9","key":"10.1016\/j.remnie.2025.500113_bib0140","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","article-title":"Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis","volume":"19","author":"Zorcolo","year":"2012","journal-title":"Ann Surg Oncol."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T01:57:03Z","timestamp":1756432623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2253808925000217"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500113","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET\/CT parameters and inflammatory markers","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500113","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500113"}}